Network origin in Ian Clark first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.
16
| Subsidiary | Biotechnology | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ian Clark via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AURA BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Vanderbilt University | College/University | Undergraduate Degree | |
The Methodist Hospital
 The Methodist Hospital Hospital/Nursing ManagementHealth Services The Methodist Hospital owns and operates general medical hospitals. The firm provides services for cancer, gastroenterology and GI surgery, neurology and neurosurgery, orthopedics, and sports medicine and transplant. The company was founded in 1919 and is headquartered in Houston, TX. | Hospital/Nursing Management | Chairman | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| McMaster University | College/University | Doctorate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member | |
| University of Wolverhampton | College/University | Undergraduate Degree | |
| University of Aston | College/University | Graduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree | |
| Sorbonne Université | College/University | Undergraduate Degree | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member President | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| Columbia Business School | College/University | Masters Business Admin | |
| LYSOGENE | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Solas Bioventures (mayfield) LLC
 Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas Bioventures (mayfield) LLC is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Investment Managers | Consultant / Advisor | |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Chief Executive Officer Director of Finance/CFO | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Infocus Capital Partners
 Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Investment Managers | Consultant / Advisor | |
Swanbio Therapeutics Ltd.
 Swanbio Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Swanbio Therapeutics Ltd. engages in the research and experimental development of biotechnology. The company was founded on September 1, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| OLEMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Geisel School of Medicine | College/University | Doctorate Degree | |
Orbit Biomedical Ltd.
 Orbit Biomedical Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the company is based in Stevenage, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chairman | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Chairman | |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Director/Board Member | |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
| Retina Consultants of Houston PA | Chief Tech/Sci/R&D Officer | ||
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. develops new generation of therapies for eye diseases. The British company was founded in 2021 by David R. Guyer, Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Biotechnology | Founder Private Equity Investor | |
| Forcefield Therapeutics Ltd. | Chairman Director/Board Member | ||
| Syncona Ip Holdco Ltd. | Director/Board Member | ||
| ENGENE HOLDINGS INC. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 24 |
| United Kingdom | 18 |
| France | 4 |
| Canada | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 5 |
| Miscellaneous | 3 |
Operational
| Director/Board Member | 80 |
| Corporate Officer/Principal | 22 |
| Independent Dir/Board Member | 15 |
| Undergraduate Degree | 13 |
| Chairman | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Maha Katabi | 28 |
| Chris Hollowood | 19 |
| David Fellows | 16 |
| Jennifer Cook | 13 |
| Renée Galá | 13 |
| Anthony Adamis | 12 |
| Dominic Schmidt | 12 |
| Wouter Joustra | 10 |
| Sean Bohen | 9 |
| Khurem Farooq | 8 |
| Charles C. Wykoff | 7 |
| Baker Keith | 6 |
| Soraya Bekkali | 5 |
| Janet Hopkins | 5 |
| Arshad Khanani | 1 |
- Stock Market
- Insiders
- Ian Clark
- Company connections
